Stifel Nicolaus assumed coverage on shares of Heartflow (NASDAQ:HTFL - Free Report) in a report released on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $35.00 price objective on the stock.
Several other research analysts have also recently weighed in on the company. Wall Street Zen upgraded Heartflow to a "hold" rating in a research note on Saturday, August 16th. JPMorgan Chase & Co. started coverage on Heartflow in a research note on Tuesday, September 2nd. They set an "overweight" rating and a $36.00 price objective for the company. Canaccord Genuity Group assumed coverage on shares of Heartflow in a research report on Tuesday, September 2nd. They issued a "buy" rating and a $35.00 price target on the stock. Finally, Piper Sandler started coverage on Heartflow in a report on Tuesday, September 2nd. They set an "overweight" rating and a $38.00 price target on the stock. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $35.80.
View Our Latest Stock Report on Heartflow
Heartflow Trading Down 8.8%
NASDAQ:HTFL traded down $3.01 during trading hours on Tuesday, reaching $31.07. 442,043 shares of the company traded hands, compared to its average volume of 878,154. Heartflow has a 1 year low of $26.56 and a 1 year high of $36.68.
About Heartflow
(
Get Free Report)
We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.
Recommended Stories
Before you consider Heartflow, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.
While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
